Abstract
Background: Estrogen receptor-α positive breast cancer is the most common dreadful disease and leading cause of death among women. In majority of human breast cancer, the interactions between kinases and ERα are considered to be critical in signaling pathway. Many kinases are known to regulate ERα activity. Recently Lemur tyrosine kinase-3 was identified as predictive oncogenic ERα regulator with a vital role in endocrine resistance. The role of LMTK3 in ERα regulation can be known by studying the interactions between them.
Objectives: To understand the transient interactions between ER-α and LMTK3 using computational technique.
Method: ERα -LMTK3 complex structure was obtained using PatchDock server. The interacting residues and interface area between ERα and LMTK3 were identified using PDBsum. Molecular dynamics simulation was used to study the conformational dynamics of ERα -LMTK3 complex.
Result: The approximate interface area of ERα-LMTK3 was found to be 3175 Å2 with atomic contact energy of 191.77 kcal/mol. PDBsum results revealed that some of the residues in C-terminal region of LMTK3 displayed non-bonding interactions with the residues in the phosphorylation sites (Ser104 and Ser106) of ERα. We noticed the total number of interface residues in ERα-LMTK3 complex to be 50 and the interface area for ERα as well as LMTK3 chain involved in interaction to be more than 2380 Å2. From conformational dynamics study, ERα-LMTK3 complex structure was found to be stable.
Conclusion: The outcomes of the current study enhance the understanding of interactions between ERα and LMTK3 which are thought to be critical in signaling pathway in majority of human breast cancers.
Keywords: Breast cancer, endocrine resistance, molecular dynamics simulation, PatchDock, PDBsum.
Graphical Abstract
Current Proteomics
Title:Unveiling the Transient Protein-Protein Interactions that Modulate the Activity of Estrogen Receptor(ER)-α by Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: An In Silico Study
Volume: 14 Issue: 2
Author(s): Venkata Satish Kumar Mattaparthi*Himakshi Sarma
Affiliation:
- Molecular Modelling and Simulation Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur-784 028, Assam,India
Keywords: Breast cancer, endocrine resistance, molecular dynamics simulation, PatchDock, PDBsum.
Abstract: Background: Estrogen receptor-α positive breast cancer is the most common dreadful disease and leading cause of death among women. In majority of human breast cancer, the interactions between kinases and ERα are considered to be critical in signaling pathway. Many kinases are known to regulate ERα activity. Recently Lemur tyrosine kinase-3 was identified as predictive oncogenic ERα regulator with a vital role in endocrine resistance. The role of LMTK3 in ERα regulation can be known by studying the interactions between them.
Objectives: To understand the transient interactions between ER-α and LMTK3 using computational technique.
Method: ERα -LMTK3 complex structure was obtained using PatchDock server. The interacting residues and interface area between ERα and LMTK3 were identified using PDBsum. Molecular dynamics simulation was used to study the conformational dynamics of ERα -LMTK3 complex.
Result: The approximate interface area of ERα-LMTK3 was found to be 3175 Å2 with atomic contact energy of 191.77 kcal/mol. PDBsum results revealed that some of the residues in C-terminal region of LMTK3 displayed non-bonding interactions with the residues in the phosphorylation sites (Ser104 and Ser106) of ERα. We noticed the total number of interface residues in ERα-LMTK3 complex to be 50 and the interface area for ERα as well as LMTK3 chain involved in interaction to be more than 2380 Å2. From conformational dynamics study, ERα-LMTK3 complex structure was found to be stable.
Conclusion: The outcomes of the current study enhance the understanding of interactions between ERα and LMTK3 which are thought to be critical in signaling pathway in majority of human breast cancers.
Export Options
About this article
Cite this article as:
Kumar Mattaparthi Satish Venkata *, Sarma Himakshi, Unveiling the Transient Protein-Protein Interactions that Modulate the Activity of Estrogen Receptor(ER)-α by Human Lemur Tyrosine Kinase-3 (LMTK3) Domain: An In Silico Study, Current Proteomics 2017; 14 (2) . https://dx.doi.org/10.2174/1570164614666161206164330
DOI https://dx.doi.org/10.2174/1570164614666161206164330 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ABC Transporters and Drug Resistance in Patients with Epilepsy
Current Pharmaceutical Design Exosome as a Natural Gene Delivery Vector for Cancer Treatment
Current Cancer Drug Targets Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421
Anti-Cancer Agents in Medicinal Chemistry In Silico Approach to Finding New Active Compounds from Histone Deacetylase (HDAC) Family
Current Pharmaceutical Design The Role of CXCR3 in Neurological Diseases
Current Neuropharmacology Drug Transport Across the Placenta
Current Pharmaceutical Biotechnology Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Management of Fallopian Tube Cancer
Reviews on Recent Clinical Trials Anti-Inflammatory and Anti-Neoplastic Actions of Resveratrol
Current Nutrition & Food Science Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Applied Proteomics in Companion Animal Medicine
Current Proteomics Genito-Urological Cancers in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Neurokinin-1 Receptor Antagonist Can Prevent the Delayed Phase in Patients: A Single Center Retrospect Study
Anti-Cancer Agents in Medicinal Chemistry Focused Microarray Analysis: Characterization of Phenomes by Gene Expression Profiling
Current Pharmacogenomics ABC Transporters, Bile Acids, and Inflammatory Stress in Liver Cancer
Current Pharmaceutical Biotechnology Post-Exercise Ketosis, Salivary Uric Acid and Interleukin-6 after a Simulated Wheelchair Basketball Match
Endocrine, Metabolic & Immune Disorders - Drug Targets Mutation Mechanisms of Breast Cancer among the Female Population in China
Current Bioinformatics Quantitative Structure-Activity Relationships for Anticancer Activity of 2- Phenylindoles Using Mathematical Molecular Descriptors
Current Computer-Aided Drug Design Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Screening and Partial Purification of Cholinesterase Inhibitor from Microalgae
Current Enzyme Inhibition